Running Your Dermatology Practice During COVID-19
Step 1: Understand your community’s COVID-19 prevalence
With the current COVID-19 pandemic, many dermatology practices are operating differently. These recommendations should help you keep your practice operating safely during the pandemic. Based on the CDC definition of COVID-19 risk exposure, most dermatology practices fit into the low risk category.
Additional guidance is available at:
CMS guidance to facilities on providing non-emergent care (PDF download)
CDC has released guidance for office buildings
AMA has created “A physician guide to keeping your practice open during COVID-19” (PDF download)
AAD has assembled links to guidance from other specialty societies (PDF download)
Step 1: Understand your community’s rate of COVID-19 prevalence
Communities with greater prevalence will require more stringent procedures, while those with a lower incidence of COVID-19 may function in a different manner.
The federal government has stated that a downward trajectory of documented cases over a 14-day period should occur before opening practices to elective visits and procedures. However, most states have “opened” to various degrees in spite of rising case numbers, allowing elective visits and procedures to proceed.
Consult with your local and state public health department for local requirements. The AMA has developed a helpful chart (PDF download) summarizing each state’s directives on elective, non-urgent, or non-essential procedures. The situation is changing with some regularity as “hotspots” crop up around the country.
Have a plan in place for patients who appear with COVID-19 symptoms and may need testing. Consider finding testing locations in your area where you can recommend patients can go for testing, or refer the patient to their primary care physician. Consult the CDC’s guidance on COVID-19 testing.
Download this guidance
Use the button below to download a PDF of all steps of this guide.Download the guide
Navigate the Coronavirus Resource Center
All content solely developed by the American Academy of Dermatology